Synthetic DNA-Based Drug Is First To Slow Progress of Huntington's Disease (theguardian.com)
John.Banister writes: The Guardian reports of early success in the trial of a synthetic DNA based drug, Ionis-HTTRx, at University College London's Huntington's Disease Center. Bionews explains that this gene silencing drug binds to the RNA transcript of the faulty huntingtin gene, triggering its destruction before it can go on to make the huntingtin protein. There's much excited speculation that the same technique could be used for Alzheimer's and Parkinson's disease, once people know which genes to target. "The trial involved 46 men and women with early stage Huntington's disease in the UK, Germany and Canada," reports The Guardian. "The patients were given four spinal injections one month apart and the drug dose was increased at each session; roughly a quarter of participants had a placebo injection. After being given the drug, the concentration of harmful protein in the spinal cord fluid dropped significantly and in proportion with the strength of the dose. This kind of closely matched relationship normally indicates a drug is having a powerful effect."
A single shot, or treatment. If it goes thru the bloodstream seeking copies of a gene wouldn't it find those genes in the testes/ovaries?
No thanks. I'll take disease. It's natural therefore can't hurt me.
A single shot, or treatment. If it goes thru the bloodstream seeking copies of a gene wouldn't it find those genes in the testes/ovaries?
Probably not, although I'm not a biologist.
The cell encodes instructions for making proteins in DNA, and these are "copied" onto RNA and taken to the ribosomes where the protein is made. The DNA is kept in the nucleus, and the RNA travels to the ribosome outside the nucleus.
The current treatment binds to the RNA while in transit on its way to the ribosome. The original DNA copy is unchanged, and so when the treatment wears off (RNA binding molecules get used up) the original disease comes back.
However, pre-natal testing can determine whether a child has inherited the defective gene, giving the parents the option to abort said fetus and try for another child.
Does anyone get the reference?
If only someone would travel back in time and kill Huntington as a baby.
Instead of aborting they could fix it using CRISPR or other gene editing technology.
We don't have that capability yet, and as far as I am aware there are no such treatments on the horizon. That's at least 10 years out, more likely 20 with testing and regulation. (Note that the treatment in the OP was done in Canada, Germany, and the UK. Notably, *not* the US.)
For the next decade or two, abortion (or not) is the only choice.
So this is just a first for humans.
DNA therapy for dogs, and rich millionaires getting treatments in China.
This is something that should be corrected with germ line alterations. Rather than fix the symptom, the gene itself needs to be corrected, and corrected in the reproductive system so the defect isn't passed on to children.
I'm seeing a day when everyone's taking a cocktail of defect-masking pills on a daily basis because we've allowed these genes to spread through the population and everyone has a dozen debilitating / fatal conditions.
Why is ALS called Lou Gehrig's Disease but Huntington's is not called Woody Guthrie's Disease?
Huntington's disease: the new gene therapy that sufferers cannot afford
I simply looked up "Michael R. Hayden" and the name of the drug in question and quality reporting landed right at the top of my search results.
Hayden is active against genetic discrimination.
The House GOP is pushing a bill that would let employers demand workers' genetic test results — March 2017
Here's Ron Paul, wearing his mechanical heart on his sleeve:
Health insurance and 'genetic discrimination': Are rules needed? — January 2012
The problem is, if society imposes nothing, business tends to devolve into a crass race to the bottom with real human casualties.
So I'm generally in favour of the government foreclosing on the worst of the worst, while leaving plenty of scope for businesses to morally disgrace themselves (or not).